Clinical Report: Recent Developments in Comprehensive Approaches for Managing Solitary Fibrous Tumors of the Central Nervous System
Background
Solitary fibrous tumors of the CNS are rare neoplasms that pose significant treatment challenges due to their proximity to critical neurovascular structures. Surgical resection is the primary treatment, but recurrence rates can be as high as 43%, necessitating comprehensive postoperative management strategies. Understanding the biology and treatment options for CNS SFTs is crucial for optimizing patient outcomes.
Data Highlights
No numerical data available in the source material.
Key Findings
Maximal safe surgical resection is the cornerstone of local control for CNS SFTs.
Postoperative radiotherapy can improve local control rates for patients with subtotal resection or high-risk pathological features.
Anti-angiogenic agents like pazopanib have shown disease control in advanced SFT cases.
Cytotoxic chemotherapy is reserved for refractory or dedifferentiated subtypes of SFT.
Immunotherapy has shown limited activity in select patients, with PRAME as a potential target.
Lifelong MRI surveillance is essential for early detection of recurrence.
Clinical Implications
A multidisciplinary team approach is essential for managing CNS SFTs, with treatment decisions tailored to individual patient factors. Regular imaging surveillance is critical for monitoring recurrence and guiding further treatment.
Conclusion
Comprehensive management of CNS SFTs requires a combination of surgical, radiotherapeutic, and systemic strategies to improve patient outcomes and reduce recurrence rates.
